These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12560157)

  • 1. Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy.
    Onozato ML; Tojo A; Goto A; Fujita T
    Diabetes Res Clin Pract; 2003 Feb; 59(2):83-92. PubMed ID: 12560157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
    Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
    Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats.
    Petitjean P; Vloemans M; Barthelmebs M; Stephan D; Grima M; Jund A; Imbs JL
    Fundam Clin Pharmacol; 1994; 8(4):356-65. PubMed ID: 7851841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor.
    Fabris B; Candido R; Carraro M; Fior F; Artero M; Zennaro C; Cattin MR; Fiorotto A; Bortoletto M; Millevoi C; Bardelli M; Faccini L; Carretta R
    Diabetes; 2001 Nov; 50(11):2619-24. PubMed ID: 11679443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
    Navarro-Cid J; Maeso R; Rodrigo E; Muñoz-García R; Ruilope LM; Lahera V; Cachofeiro V
    Am J Hypertens; 1996 Nov; 9(11):1077-83. PubMed ID: 8931832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
    Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition.
    Kobayashi N; Honda T; Yoshida K; Nakano S; Ohno T; Tsubokou Y; Matsuoka H
    Atherosclerosis; 2006 Jul; 187(1):92-100. PubMed ID: 16214149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
    Kökény G; Fang L; Révész C; Mózes MM; Vörös P; Szénási G; Rosivall L
    Kidney Blood Press Res; 2017; 42(1):109-122. PubMed ID: 28359068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet.
    Onozato ML; Tojo A; Goto A; Fujita T
    Kidney Int; 2004 Mar; 65(3):951-60. PubMed ID: 14871415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
    Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
    Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in rats administered NG-nitro L-arginine methyl ester due to converting enzyme inhibition.
    Michel JB; Xu Y; Blot S; Philippe M; Chatellier G
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):142-8. PubMed ID: 8797148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
    Hoshida S; Yamashita N; Kawahara K; Kuzuya T; Hori M
    Circulation; 1999 Jan; 99(3):434-40. PubMed ID: 9918532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
    Endlich K; Steinhausen M
    J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
    Hendarto H; Inoguchi T; Maeda Y; Ikeda N; Zheng J; Takei R; Yokomizo H; Hirata E; Sonoda N; Takayanagi R
    Metabolism; 2012 Oct; 61(10):1422-34. PubMed ID: 22554832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.